151 related articles for article (PubMed ID: 9694371)
21. Biochemical and cellular characterisation of the Plasmodium falciparum M1 alanyl aminopeptidase (PfM1AAP) and M17 leucyl aminopeptidase (PfM17LAP).
Mathew R; Wunderlich J; Thivierge K; Cwiklinski K; Dumont C; Tilley L; Rohrbach P; Dalton JP
Sci Rep; 2021 Feb; 11(1):2854. PubMed ID: 33536500
[TBL] [Abstract][Full Text] [Related]
22. Characterization and partial purification of a leucine aminopeptidase from Fasciola hepatica.
Acosta D; Goñi F; Carmona C
J Parasitol; 1998 Feb; 84(1):1-7. PubMed ID: 9488329
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
[TBL] [Abstract][Full Text] [Related]
24. M17 leucine aminopeptidase of the human malaria parasite Plasmodium vivax.
Lee JY; Song SM; Seok JW; Jha BK; Han ET; Song HO; Yu HS; Hong Y; Kong HH; Chung DI
Mol Biochem Parasitol; 2010 Mar; 170(1):45-8. PubMed ID: 19931315
[TBL] [Abstract][Full Text] [Related]
25. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.
Maric S; Donnelly SM; Robinson MW; Skinner-Adams T; Trenholme KR; Gardiner DL; Dalton JP; Stack CM; Lowther J
Biochemistry; 2009 Jun; 48(23):5435-9. PubMed ID: 19408962
[TBL] [Abstract][Full Text] [Related]
26. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
Burley SK; David PR; Lipscomb WN
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
Taylor A; Peltier CZ; Torre FJ; Hakamian N
Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
[TBL] [Abstract][Full Text] [Related]
28. The slow, tight binding of bestatin and amastatin to aminopeptidases.
Wilkes SH; Prescott JM
J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258
[TBL] [Abstract][Full Text] [Related]
29. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
Yanow SK; Purcell LA; Spithill TW
Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
[TBL] [Abstract][Full Text] [Related]
30. Gene synteny and chloroquine resistance in Plasmodium chabaudi.
Hunt P; Martinelli A; Fawcett R; Carlton J; Carter R; Walliker D
Mol Biochem Parasitol; 2004 Aug; 136(2):157-64. PubMed ID: 15478795
[TBL] [Abstract][Full Text] [Related]
31. Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum.
Dalal S; Klemba M
J Biol Chem; 2007 Dec; 282(49):35978-87. PubMed ID: 17895246
[TBL] [Abstract][Full Text] [Related]
32. The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes.
Gavigan CS; Dalton JP; Bell A
Mol Biochem Parasitol; 2001 Sep; 117(1):37-48. PubMed ID: 11551630
[TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of an aminopeptidase from Plasmodium falciparum.
Vander Jagt DL; Baack BR; Hunsaker LA
Mol Biochem Parasitol; 1984 Jan; 10(1):45-54. PubMed ID: 6363922
[TBL] [Abstract][Full Text] [Related]
34. Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.
Harbut MB; Velmourougane G; Dalal S; Reiss G; Whisstock JC; Onder O; Brisson D; McGowan S; Klemba M; Greenbaum DC
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E526-34. PubMed ID: 21844374
[TBL] [Abstract][Full Text] [Related]
35. Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo.
He Z; Qin L; Chen L; Peng N; You J; Chen X
Antimicrob Agents Chemother; 2008 Jul; 52(7):2653-6. PubMed ID: 18443126
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
Rich DH; Moon BJ; Harbeson S
J Med Chem; 1984 Apr; 27(4):417-22. PubMed ID: 6142952
[TBL] [Abstract][Full Text] [Related]
37. Schistosoma mansoni: purification and characterization of a membrane-associated leucine aminopeptidase.
Xu YZ; Shawar SM; Dresden MH
Exp Parasitol; 1990 Feb; 70(2):124-33. PubMed ID: 2298275
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatin.
Frick L; Wolfenden R
Biochim Biophys Acta; 1985 Jul; 829(3):311-8. PubMed ID: 3890953
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of leucine aminopeptidase 3 suppresses invasion of ovarian cancer cells through down-regulation of fascin and MMP-2/9.
Wang X; Shi L; Deng Y; Qu M; Mao S; Xu L; Xu W; Fang C
Eur J Pharmacol; 2015 Dec; 768():116-22. PubMed ID: 26526349
[TBL] [Abstract][Full Text] [Related]
40. Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.
Pulido-Cejudo G; Conway B; Proulx P; Brown R; Izaguirre CA
Antiviral Res; 1997 Dec; 36(3):167-77. PubMed ID: 9477117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
